Has Petros Benias, MD received payments from drug or device companies?

Yes. Drug and device makers reported $130,323 in general payments to Petros Benias, MD across 228 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Petros Benias, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Petros Benias, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Petros Benias, MD

Gastroenterology · New, NYNPI 1649429077

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Boston Scientific at 38.7% of the total. Reporting peaked in 2023 at $34,820 and has fallen 86.4% since, to $4,740 in 2025. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$130,323in general payments, 2019–2025

Across 228 payments — averaging $571.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$50K
Fujifilm Healthcare Americas Corporation$25K
Micro-tech Endoscopy USA, Inc.$21K
Apollo Endosurgery US Inc$15K
Covidien LP$6K
Olympus Corporation Of The Americas$5K
plus $7K from 11 others

What the payments were for

Royalty or licence$4,2773%
Consulting fees$68,90053%
Speaking & faculty fees$36,51028%
Grants$5000%
Travel & lodging$10,8708%
Food & beverage$9,2667%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	108	$50,387
Fujifilm Healthcare Americas Corporation	21	$24,917
Micro-tech Endoscopy USA, Inc.	28	$21,324
Apollo Endosurgery US Inc	22	$14,567
Covidien LP	4	$6,226
Olympus Corporation Of The Americas	6	$5,408
Creo Medical Inc.	5	$4,283
Olympus America Inc.	13	$891
Medtronic	8	$838
Olympus Corporation	1	$644
ERBE USA Inc	4	$501
Merit Medical Systems Inc	1	$130
Endogastric Solutions, Inc	2	$68
Pentax Of America, Inc.	2	$64
3-d Matrix, Inc.	1	$44
QOL Medical, LLC	1	$19
Pfizer	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ESD - Core Endoscopy$15,800
X-Tack Endoscopic HeliX Tacking System$9,511
Overstitch$9,077
GoldKnife$8,187
GENERAL - THERAPIES$6,135
Olympus EMR & ESD Devices$5,408
OverStitch Endoscopic Suturing System$4,756
OverStitch Endoscopic Suturing System Sx$4,756
ACQUIRE$3,898
RESOLUTION CLIP$3,881
Orbera$2,873
X-tack$2,873
SPEEDBOAT$2,163
Creo Medical$2,000
AXIOS$1,006
GENERAL - BILIARY DEVICES$885
FUJIFILM$884
GENERAL HEMOSTASIS$654
Hemostasis Clips$644
Core GI$450

How this compares

$130,323 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024

$84,252

Medicare patients

218

Services billed

557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	20	$226

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New

David Carr LockeNew York$2M
Arthur KornbluthNew York$1.9M
Maya SrivastavaWilliamsville$1.8M
Melissa PalmerPlainview$1M
Sonal KumarNew York$1M
David PoppersNew York$939K
Ellen ScherlNew York$857K
Bruce SandsNew York$810K
Jean Frederick ColombelNew York$786K
Seth GrossNew York$624K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →